Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Inks Deal to Buy Signature Genomic Laboratories

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer said today that it has bolstered its genetic testing business by agreeing to buy Spokane, Wash.-based Signature Genomic Laboratories for an undisclosed sum.

Signature, which has around 120 employees, provides diagnostic cytogenetic testing for chromosome abnormalities in people with unexplained physical and developmental disabilities. It offers microarray-based diagnostic tests for both pre-natal and post-natal identification of DNA alterations associated with genetic diseases, and it recently launched services for diagnosing patients with leukemia.

"As a global leader in genetic screening technologies and services, PerkinElmer clearly has the resources and worldwide presence to enable our combined testing services to reach more patients and families," Signature Genomic Laboratories Co-founder Lisa Shaffer said in a statement.

PerkinElmer CEO Robert Friel said that the new addition will bring with it "very strong complementary assets for diagnosing disorders that are often undetected by traditional genetic tests."

PerkinElmer said it expects the deal for Signature to close sometime in May, after the regulatory waiting period under the Hart-Scott Rodino Antitrust Improvements Act expires.

Financial terms of the agreement were not released.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.